Longyong Xu
0000-0002-8574-4062
Publication & Citation Trends
Most Cited Works
Publications
51 total
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer PDF
Cited by 49
OpenAlex
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity OA
Cited by 0
Semantic Scholar
CRISPR/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer PDF
Cited by 46
OpenAlex
Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells PDF
Cited by 32
OpenAlex
Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β−selection PDF
Cited by 33
OpenAlex
Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions PDF
Cited by 58
OpenAlex
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer PDF
Cited by 258
OpenAlex
Research Topics
Bone health and treatments
(15)
Epigenetics and DNA Methylation
(12)
Chemical Reactions and Isotopes
(7)
Cancer-related gene regulation
(6)
Bone Tumor Diagnosis and Treatments
(5)
Frequent Co-Authors
Affiliations
The University of Texas MD Anderson Cancer Center
MRC Laboratory of Molecular Biology
Baylor College of Medicine
Chinese Academy of Sciences
Shanghai Institutes for Biological Sciences